{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "EUR", "marketState": "REGULAR", "regularMarketChangePercent": 35.401455, "regularMarketPrice": 0.0742, "exchange": "FRA", "shortName": "ASARINA PHARMA AB", "longName": "Asarina Pharma AB (publ)", "messageBoardId": "finmb_62290254", "exchangeTimezoneName": "Europe/Berlin", "exchangeTimezoneShortName": "CEST", "gmtOffSetMilliseconds": 7200000, "market": "dr_market", "esgPopulated": false, "regularMarketTime": 1683892037, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -0.05, "sharesOutstanding": 22641400, "fiftyDayAverage": 0.155196, "fiftyDayAverageChange": -0.080996, "fiftyDayAverageChangePercent": -0.52189493, "twoHundredDayAverage": 0.100535, "twoHundredDayAverageChange": -0.026335001, "twoHundredDayAverageChangePercent": -0.2619486, "marketCap": 2660611, "sourceInterval": 15, "exchangeDataDelayedBy": 15, "tradeable": false, "cryptoTradeable": false, "firstTradeDateMilliseconds": 1596434400000, "priceHint": 4, "regularMarketChange": 0.019399997, "regularMarketDayHigh": 0.0742, "regularMarketDayRange": "0.0614 - 0.0742", "regularMarketDayLow": 0.0614, "regularMarketVolume": 3000, "regularMarketPreviousClose": 0.0548, "bid": 0.0626, "ask": 0.1225, "fullExchangeName": "Frankfurt", "financialCurrency": "SEK", "regularMarketOpen": 0.0614, "averageDailyVolume3Month": 0, "averageDailyVolume10Day": 0, "fiftyTwoWeekLowChange": 0.027199998, "fiftyTwoWeekLowChangePercent": 0.5787234, "fiftyTwoWeekRange": "0.047 - 0.3", "fiftyTwoWeekHighChange": -0.22580001, "fiftyTwoWeekHighChangePercent": -0.75266665, "fiftyTwoWeekLow": 0.047, "fiftyTwoWeekHigh": 0.3, "symbol": "APS.F"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "Karolinska Institutet Science Park", "address2": "Fogdevreten 2", "city": "Solna", "zip": "171 65", "country": "Sweden", "phone": "46 8 52 48 44 82", "website": "https://www.asarinapharma.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Asarina Pharma AB (publ), a biotech company, researches and develops pharmaceutical products. Its flagship product is Sepranolone, which is used for the treatment of menstrual migraine and Tourette syndrome. The company was formerly known as Umecrine Mood AB and changed its name to Asarina Pharma AB (publ) in 2016. Asarina Pharma AB (publ) was incorporated in 2005 and is based in Solna, Sweden.", "fullTimeEmployees": 1, "companyOfficers": [{"maxAge": 1, "name": "Mr. Peter  Nordkild", "age": 67, "title": "CEO & Chief Medical Officer", "yearBorn": 1955, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Jakob Dynnes Hansen M.Sc., MBA", "age": 67, "title": "Chief Financial Officer", "yearBorn": 1955, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Torbj\u00f6rn  B\u00e4ckstr\u00f6m M.D., Ph.D.", "age": 74, "title": "Chief Science Officer & Chairman of Scientific Advisory Board", "yearBorn": 1948, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mark  DuBois", "title": "Communications Mang.", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Otto  Skolling M.Sc", "age": 61, "title": "Chief Bus. Officer", "yearBorn": 1961, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "maxAge": 86400}}], "error": null}}